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 Equine Uveitis, a Spontaneous Model of Recurrent 
Uveitis 
 Standard animal models for the investigation of auto-
immune uveitis are experimentally induced uveitis in 
Lewis rats or in mice  [1] . The only spontaneous model of 
recurrent uveitis is equine recurrent uveitis (ERU), a dis-
ease that occurs with high frequency (10%) in horses. 
ERU closely resembles human autoimmune uveitis re-
garding clinical and immune pathological aspects  [2] . 
The spontaneous remitting-relapsing character of this 
disease discloses the value of the equine model in study-
ing events initiating uveitis and uveitic relapses. Autoim-
mune uveitis is assigned to the organ-specific, T-cell-me-
diated autoimmune diseases. Infiltrating T cells are de-
tectable in high proportions in the inner eyes of horses 
with ERU, forming even lymphoid follicles in the iris 
stroma  [2] . Analyses of autoantigen and epitope specific-
ity of these autoaggressive T cells revealed evidence for 
inter- and intramolecular epitope spreading  [3, 4] . Im-
mune reactions of horses were directed against the major 
retinal autoantigens S-antigen (S-Ag)  [5, 6] and interpho-
toreceptor retinoid-binding protein (IRBP)  [6, 7] but also 
against other proteins expressed in the retinal proteome 
 [8] . The shifts in immunoreactivity could account for the 
remitting-relapsing character of the disease.
 Key Words 
 Uveitis, spontaneous model, horse   Autoimmune   Target 
organ   Autoantigens   Proteomics   Regulated proteins 
 Abstract 
 Equine recurrent uveitis (ERU) is an autoimmune disease that 
occurs with a high prevalence (10%) in horses. ERU repre-
sents the only reliable spontaneous model for human auto-
immune uveitis. We already identified and characterized 
novel autoantigens (malate dehydrogenase, recoverin, 
CRALBP) by analyzing the autoantibody-binding pattern of 
horses affected by spontaneous recurrent uveitis (ERU) to 
the retinal proteome. CRALBP also seems to be relevant to 
human autoimmune uveitis. Proteomic screening of vitre-
ous and retinal samples from ERU diseased cases in com-
parison to healthy controls has led to the identification of a 
series of differentially regulated proteins, which are func-
tionally linked to the immune system and the maintenance 
of the blood-retinal barrier.  Copyright © 2008 S. Karger AG, Basel 
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 Detection of Novel Autoantigens Using the Equine 
Uveitis Model 
 Further examination of the autoimmune repertoire 
in ERU cases using the retinal proteome as autoanti-
genic source led to the identification of malate dehydro-
genase (MDH), recoverin  [8] and CRALBP  [8] as poten-
tial novel ERU autoantigens. A further advantage of the 
horse model is that the horse itself can be used as an ex-
perimental animal model, thus allowing the direct ver-
ification of hypotheses created through investigating 
the spontaneous disease. The pathological potential of 
the candidate autoantigens MDH and CRALBP  [8] was 
therefore directly tested in the horse as a last step of the 
full characterization of these autoantigens. CRALBP 
proved its uveitogenicity in the horse and we could di-
rectly compare the ensuing pathology in induced and 
spontaneous uveitis  [8] . In contrast, MDH injections 
did not induce uveitis despite considerable autoanti-
body formation and auto aggressive, MDH-specific T 
cells. The relevance of CRALBP as a novel autoantigen 
also for human auto immune uveitis was recently dem-
onstrated in first experiments showing a high propor-
tion of uveitis patients positive for anti-CRALBP auto-
antibody [9].
 Interestingly, the validation of the retinal autoantigens 
IRBP and S-Ag pointed to a major role of IRBP as auto-
antigen in the horse model of uveitis  [10] . Uveitis was in-
ducible with an incidence of 100% in experimental hors-
es and was also reinducible several times in a well-de-
fined manner  [10] . In contrast, S-Ag induced uveitis in 
20% of the cases and uveitis was monophasic  [11] , as also 
seen in the Lewis rat  [1] . Interestingly, all horses that were 
injected with S-Ag developed anti-S-Ag autoantibodies 
with high titer and also autoreactive T cells reacting to in 
vitro stimulation with S-Ag-derived peptides  [11] . Never-
theless, these T cells did not overcome the blood-retinal 
barrier in the majority of the tested cases.
 Differentially Regulated Proteins in the Uveitis 
Target Organs 
 Therefore, further insight into the disease mecha-
nisms caused by the target organ itself is needed. System-
atic exploration of the intraocular proteomes of sponta-
neous uveitis cases and healthy controls enabled the 
identification of several differentially regulated proteins 
that belong to pathways involved in immune response 
 [12, 13] . The respective upregulated proteins are comple-
ment component C3, carboxylesterase D1 and histone 
deacetylase complex subunit SAP18, which merit further 
exploration in the context of spontaneous uveitis. C3 is a 
member of the complement cascade that can be activated 
in 3 different pathways: the classical, alternate and lectin 
pathways. All three pathways merge at a common inter-
section, complement component C3. C3 split products 
have been reported to be deposited in large quantities 
under pathological conditions such as diabetic retinopa-
thy  [14] . Furthermore, intraocular complement activa-
tion, specifically the involvement of complement recep-
tor 3, had a significant impact on disease activity in ex-
perimental autoimmune uveitis in rats  [15, 16] . The 
second candidate, carboxylesterase D1, is a serine ester-
ase that is highly similar to human monocyte/macro-
phage serine esterase 1  [17] . Esterase activity in human 
monocytes has been demonstrated to correlate with che-
motaxis  [18] . Histone deacetylase complex subunit SAP18 
is a transcription factor. SAP18 is expressed during mu-
rine  hematopoietic precursor differentiation, as well as 
in  bipotent erythroid/megakaryocytic precursors and in 
maturing monocytes and megakaryocytes  [19] . Since 
macrophages are detectable in considerable amounts in 
uveitic retinas  [2] , the expression of a transcription factor 
leading to macrophage differentiation in diseased re-
tina also merits further investigation from our point of 
view.
 Stable Expression of Autoantigens in all Stages 
of Uveitis  
 In both diseases, ERU and autoimmune recurrent uve-
itis of man, uveitic relapses are notable even in phthisical 
and blind eyes  [20] . Histopathological examination of 
ERU eyes and eyes from experimentally induced uveiti-
des revealed an almost complete loss of the photoreceptor 
outer segments in advanced stages of disease  [1, 2] . Since 
the photoreceptor outer segments host 2 major autoanti-
gens, retinal S-Ag (arrestin) and IRBP  [21] , the ongoing 
immune pathology after destruction of the physiological 
expression sites of these proteins is difficult to explain. In 
other autoimmune diseases, such as Hashimoto’s thy-
roiditis, a termination of autoimmune attacks is notable 
after depletion of autoantigens  [22, 23] . We therefore ex-
amined the autoantigen expression levels of IRBP, S-Ag 
and CRALBP in uveitic retinas of several clinical stages 
in comparison to healthy control retinas. Major retinal 
autoantigens, IRBP, S-Ag and CRALBP, were clearly de-
tectable in retinal proteomes of normal equine retina and 
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in retinas with different stages of uveitis. Although the 
composition of retinal proteomes differs considerably be-
tween healthy and diseased states  [12] , the IRBP, S-Ag 
and CRALBP amounts remained unchanged  [24] . Sub-
stantial photoreceptor damage in uveitic retinas tested in 
this study was evident by measuring rhodopsin expres-
sion levels that were reduced to 27% of the original ex-
pression. The unchanged total amount of 3 major retinal 
autoantigens indicates that the autoantigenic target pro-
tein is present despite considerable destruction of their 
hosting structures and can thus trigger unabated relapses 
in patients with blind eyes. 
 Conclusions 
 Our research exploits the advantages of this sponta-
neous animal model, enabling us to characterize the 
pathomechanisms, triggering disease from the perspec-
tive of the target organ itself as well as the immune reac-
tion.
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